ROBERT KNIGHT: Open Payments
NPI 1639258932 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,845 in 93 payments from 20 companies in 2025. Trend: 2023 $2,319 · 2024 $1,856 · 2025 $1,845
Food & beverage: $1,845
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $261 |
| Lilly USA, LLC | 13 | $259 |
| AstraZeneca Pharmaceuticals LP | 11 | $232 |
| ABBVIE INC. | 13 | $225 |
| Amgen Inc. | 10 | $198 |
| Exact Sciences Corporation | 7 | $146 |
| PFIZER INC. | 6 | $117 |
| Janssen Pharmaceuticals, Inc | 3 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $59 |
Products named: MOUNJARO, FARXIGA, EVENITY, The Cologuard Plus Collection Kit, Rybelsus, Ozempic, UBRELVY, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
